Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ingrid Adamsons"'
Autor:
Richard E Pratley, Christopher P Cannon, David Z I Cherney, Francesco Cosentino, Darren K McGuire, Margaret Noyes Essex, David Lawrence, Philip L S Jones, Jie Liu, Ingrid Adamsons, Samuel Dagogo-Jack
Publikováno v:
The Lancet Healthy Longevity. 4:e143-e154
Autor:
Albert J. Getson, Christopher Lines, Jean K. Laurence, David J. Hewitt, Tony W. Ho, Arthur Shedden, Ingrid Adamsons
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 248:1757-1764
The aim of this study was to compare the efficacy and tolerability of preservative-free (PF) and preservative-containing (PC) formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure (IOP).A
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 21:242-249
In previous analyses of primary efficacy data from two randomized clinical trials, standard dosing regimens of the dorzolamide/timolol fixed combination (COSOPT) and latanoprost (XALATAN) were shown to have equivalent efficacy with regard to reductio
Autor:
P. Juhani Airaksinen, Ingrid Adamsons, Robert D. Fechtner, Christopher Lines, Albert J. Getson
Publikováno v:
Acta Ophthalmologica Scandinavica. 82:42-48
Purpose: To compare the efficacy of the fixed dorzolamide 2%/timolol 0.5% combination (COSOPT™) versus latanoprost 0.005% (XALATAN™). Methods: Two 3-month, parallel group, randomized, observer-masked and patient-masked, multicentre, clinical tria
Publikováno v:
Ophthalmology. 105:1945-1951
Objective To compare the efficacy and safety of a fixed combination of 2.0% dorzolamide and 0.5% timolol administered twice daily with each of the individual components administered in their usual monotherapy dose regimens in patients who had washed
Publikováno v:
Ophthalmology. 105:1936-1944
Objective To evaluate whether a fixed combination of 2% dorzolamide and 0.5% timolol given twice daily showed equivalent efficacy to the concomitant administration of 2% dorzolamide given three times daily and 0.5% timolol given twice daily in patien
Publikováno v:
Ophthalmology. 105:1952-1959
Objective To compare the dorzolamide-timolol fixed combination twice daily to its components, timolol maleate and dorzolamide hydrochloride, given in their usual monotherapy regimens in patients whose intraocular pressure (IOP) was not controlled on
Publikováno v:
Clinical Therapeutics. 20:454-466
A multicenter, parallel-design, randomized, double-masked study was conducted to compare the efficacy and safety of 2% dorzolamide with those of 0.5% betaxolol in the treatment of elevated intraocular pressure (IOP). A total of 311 adults with ocular
Publikováno v:
Clinical Therapeutics. 18:821-832
The purpose of this study was to compare 2% dorzolamide three times daily with 2% pilocarpine four times daily to determine patient preference, tolerability, and impact on daily life in patients concurrently receiving 0.5% timolol twice daily for tre
Autor:
Davide Poli, Michael A. Kass, Irene Floriani, Mae O. Gordon, Julia A. Beiser, Feng Gao, Ingrid Adamsons, Torri, Stefano Miglior, J. P. Miller
Publikováno v:
Ophthalmology. 115(11)
Objective: This report compares the accuracy of 3 prediction models for the development of primary open-angle glaucoma (POAG). The models differ primarily in their handling of these eye-specific variables: intraocular pressure (IOP), central corneal